OCS™ Liver
The OCS Liver is an FDA approved device for DCD and DBD donor Livers.
Successful Completion of 300 Patient US FDA Pivotal Trial for Expanded Criteria and DCD Donor Livers
A prospective, pivotal, randomized trial to evaluate the effectiveness of the OCS Liver to preserve and assess donor livers intended for transplantation.
- Incidence of Early Liver Allograft Dysfunction (EAD) [ Time Frame: 7 days ]
- Incidence of liver graft related Serious Adverse Events (SAEs) [ Time Frame: 30 days ]
Locate an OCS Liver Center Near You
The OCS Liver device is an investigational device limited by federal law to investigational use in the US.
Massachusetts General Hospital
Main Campus
55 Fruit Street
Boston, MA 02114
(617) 726-2000
Houston Methodist Hospital
6565 Fannin St
Houston, TX 77030
Henry Ford Hospital
2799 W Grand Blvd
Detroit, MI 48202
UT Southwestern Medical Center
5323 Harry Hines Blvd
Dallas, TX 75390
Emory University Hospital
1365 Clifton Road Northeast, Building B
Atlanta, GA 30322
(855) 366-7989
University of Minnesota Medical Center
909 Fulton St. SE
Minneapolis, MN 55455
(612) 273-8383
University of Washington Medical Center
9725 3rd Ave NE #400
Seattle, WA 98115
(206) 598-3300
University of CA San Francisco Medical Center
505 Parnassus Ave
San Francisco, CA 94143
(415) 353-1664
Ohio State University Medical Center
410 W 10th Ave
Columbus, OH 43210
Scripps Green Hospital
10666 N. Torrey Pines Rd.
La Jolla, CA 92037
(858) 554-9100
University Hospital
4502 Medical Drive
MS 18-1
San Antonio, TX
78229
(210) 567-5777
Montefiore Medical Center
111 East 210 Street
Bronx, NY 10467
718-920-4321
The Nebraska Medical Center
42nd and Emile
Omaha, NE 68198
402-559-4000
University of California San Diego Medical Center
9300 Campus Point Drive
San Diego, CA 92037
619-543-6222
Stanford Hospital
300 Pasteur Drive
Stanford, CA 94305
(650) 723-5771
Atrium Health Transplant Center
1025 Morehead Medical Drive Suite 600
Charlotte, NC 28204
(800) 562-5752
Beth Israel Deaconess Medical Center
110 Francis St
Boston, MA 02215
(617) 632-1070
Cedars-Sinai Medical Center
Los Angeles, CA 90048
(310) 423-5460
NewYork-Presbyterian Hospital/Columbia
New York, NY 10032
(800) 227-2762
Duke University Medical Center
Durham, NC 27710
(919) 372-3345
Intermountain Medical Center
Murray, UT 84107
(801) 507-7000
Mayo Clinic
Phoenix, AZ 85054
(480) 342-2000
Mayo Clinic
Jacksonville, FL 32224
(904) 956-3309
St. Louis University Hospital
St. Louis, MO 63104
(314) 257-8000
Scripps
(858) 834-1798
Ronald Reagan UCLA Medical Center
Los Angeles, CA 90095
(310) 825-9111
University of Alabama at Birmingham
Birmingham, AL
(205) 934-4011
University of Michigan Hospital
Ann Arbor, MI 48109
(734) 936-4000
University of Pittsburg Medical Center
Pittsburgh, PA 15213
(800) 533-8762
Yale New Haven Transplant Center
New Haven, CT 06519
(203) 785-2565
Baylor University Medical Center, part of Baylor
Dallas TX 75246
(214) 820-0111
Mayo Clinic
Rochester, Minnesota 55905
(507) 284-2511
UMass Memorial Medical Center
(508) 334-3452
NewYork-Presbyterian / Weill Cornell Medical Center
New York, NY 10065
(212) 746-5454
Oregon Health & Science University
Portland, OR 97239
(503) 494-8311
VCU Medical Center
Richmond, VA 23219
(804) 828-9000
WISE - Froedtert Luth Memorial Hospital
Milwaukee, WI 53226
(414) 805-6644
Lahey Hospital & Medical Center
Burlington, MA 01805
(781) 744-5100
Thomas Jefferson University Hospital
Philadelphia, PA 19107
(215) 955-6000
The OCS Lung, OCS Heart and OCS Liver are all CE marked devices. The OCS Lung is an FDA approved device for standard and expanded1 criteria donor lungs. The OCS Heart is an FDA approved device for expanded2 criteria donor hearts. The OCS Liver is an FDA approved device for DCD3 and DBD donor Livers.
1. Expanded criteria lungs is defined as donor lung pairs initially deemed unacceptable for procurement and transplantation based on limitations of cold static preservation.
2. Expanded criteria hearts is defined as donor hearts that are deemed unsuitable for procurement and transplantation at initial evaluation due to limitations of prolonged cold static cardioplegic preservation (e.g., > 4 hours of cross-clamp time).
3. DCD livers < 55 years old with < 30 mins warm ischemia time and macrosteatosis < 15%.
Only multi-organ platform used with donor lungs, hearts and livers
Largest user base at 70 leading US and global transplant centers
Largest body of literature and clinical evidence in warm perfusion
Most extensive training program including 24/7 clinical support